Rhythm Pharmaceuticals, Inc(NASDAQ:RYTM) 
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of ...
Website: http://www.rhythmtx.com
Founded: 2008
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 47.81
H 49.05
L 46.20
C 46.95
V 582,683
10EMA 46.95
20EMA 46.95
60EMA 46.95
120EMA 46.95
250EMA 46.95